Pamidi Madhavi MD is categorized under Internal Medicine Doctors in West Orange, NJ and active since 2010.
Pamidi Madhavi MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Madhavi Pamidi at the company’s single location by writing to 375 Mount Pleasant Avenue, West Orange, New Jersey NJ 07052 or by phoning (973) 731-9598. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pamidi Madhavi MD |
| Contact Person: | Madhavi Pamidi |
| Address: | 375 Mount Pleasant Avenue, West Orange, New Jersey 07052 |
| Phone Number: | (973) 731-9598 |
| Website Address: | njcaheart.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Pamidi Madhavi MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Madhavi Pamidi for inquiries that concern Pamidi Madhavi MD by calling the company number (973) 731-9598, as your correspondence is most welcome. Additionally, the physical location of the single location of Pamidi Madhavi MD can be found at the coordinates 40.79016,-74.26062 as well as the street address 375 Mount Pleasant Avenue in West Orange, New Jersey 07052.
For its online presence, you may visit Pamidi Madhavi MD’s website at njcaheart.com and engage with its social media outlets through on Twitter and on Facebook.